考虑使用 Romosozumab 的骨质疏松症患者的心血管风险评估。
Cardiovascular risk assessment for osteoporosis patients considering Romosozumab.
机构信息
Cardiology, Gloucestershire Hospitals NHS Foundation Trust, Gloucester, UK.
Musculoskeletal Research Unit, University of Bristol, Bristol, UK.
出版信息
Bone. 2025 Jan;190:117305. doi: 10.1016/j.bone.2024.117305. Epub 2024 Oct 23.
PMID:39454743
Abstract
Cardiovascular risk scoaring tools are suitable for but not interchangable within the osteoporosis clinic.
摘要
心血管风险评分工具适用于骨质疏松症诊室，但不能相互替换。
Zotero 插件